| Name | EDO-S101 | CAS# | 1236199-60-2 | |
|---|---|---|---|---|
| Price | ¥Inquiry/1g | Purity | 98.9% | |
| Stocking Period |
1 Day | Stock | In Stock |
| Detail
Product Information
Tinostamustine is the first representative of the A-DAC principle, a new approach in chemotherapy that uses fusion technology to combine an alkylating agent with a pan-histone deacetylase inhibitor (HDAC) to simultaneously damage DNA and block damage repa |
Get all suppliers by the below link:
| 2024-07-15 |
EDO-S101
Price: Inquiry |
| 2020-01-06 |
Tinostamustine(EDO-S101)
Price: $600.0 |
| 2021-07-26 |
7-(5-(1,5-dichloropentan-3-yl)-1-Methyl-1H-benzo[d]imidazol-2-yl)-N-hydroxyheptanamide
Price: $Inquiry |
| 2023-09-26 |
EDO-S101
Price: ¥Inquiry |
| 2022-09-18 |
EDO-S101
Price: ¥Inquiry |
| 2024-03-12 |
EDO-S101
Price: ¥Inquiry |
| 2021-04-03 |
EDO-S101
Price: ¥1065.0 |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved


